BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9656778)

  • 21. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology and treatment of chronic myeloid leukemia.
    Jones RJ
    Curr Opin Oncol; 1997 Jan; 9(1):3-7. PubMed ID: 9090488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):153-8. PubMed ID: 10641573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone marrow transplantation in chronic myeloid leukemia].
    Milone JH; Bordone J; Etchegoyen O; Napal J; Prates MV; Morales VH
    Medicina (B Aires); 1999; 59(1):1-10. PubMed ID: 10349111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes.
    Serody JS; Brecher ME; Dent G; Bentley SA; Frelinger JA; Shea TC
    Cancer Res; 1997 Apr; 57(8):1547-53. PubMed ID: 9108458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
    Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
    Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
    Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
    [No Abstract]   [Full Text] [Related]  

  • 30. Graft-versus-host reactions: anti-leukemia effects of donor T cells.
    Flowers ME; Sullivan KM; Deeg HJ
    Transplant Proc; 1996 Jun; 28(3):1184-5. PubMed ID: 8658620
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chronic myeloid leukemia--case report].
    Hentrich M; Stoetzer OJ; Salat C; Ledderose G
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2617. PubMed ID: 12469273
    [No Abstract]   [Full Text] [Related]  

  • 32. Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects.
    Lion T
    Leukemia; 1996 May; 10(5):896-900; discussion 901-6. PubMed ID: 8656687
    [No Abstract]   [Full Text] [Related]  

  • 33. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
    Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes.
    Slavin S; Ackerstein A; Morecki S; Gelfand Y; Cividalli G
    Bone Marrow Transplant; 2001 Oct; 28(8):795-8. PubMed ID: 11781634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ultraviolet B irradiation on human natural killer cell and lymphokine activated killer cell activity: therapeutic potential in bone marrow transplantation and tumor immunotherapy.
    Yaron I; Zakheim AR; Oluwole SF; Hardy MA
    Transplant Proc; 1995 Feb; 27(1):1379. PubMed ID: 7878918
    [No Abstract]   [Full Text] [Related]  

  • 37. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
    Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Donor leukocyte transfusion for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation].
    Murata R; Shiohara S; Nakao S
    Rinsho Ketsueki; 2000 Apr; 41(4):288-91. PubMed ID: 10846457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.